London Company of Virginia’s Amgen AMGN Stock Holding History

London Company of Virginia’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$269K	–	167
2023 Q3	$269K	Hold	1,000	–	–	﹤0.01%	157
2023 Q2	$222K	Sell	1,000 -152	-13%	-$35.3K	﹤0.01%	159
2023 Q1	$278K	Hold	1,152	–	–	﹤0.01%	154
2022 Q4	$303K	Hold	1,152	–	–	﹤0.01%	154
2022 Q3	$260K	Hold	1,152	–	–	﹤0.01%	157
2022 Q2	$280K	Hold	1,152	–	–	﹤0.01%	157
2022 Q1	$279K	Hold	1,152	–	–	﹤0.01%	158
2021 Q4	$259K	Hold	1,152	–	–	﹤0.01%	161
2021 Q3	$245K	Hold	1,152	–	–	﹤0.01%	155
2021 Q2	$281K	Hold	1,152	–	–	﹤0.01%	148
2021 Q1	$287K	Hold	1,152	–	–	﹤0.01%	144
2020 Q4	$265K	Sell	1,152 -5	-0.4%	-$1.15K	﹤0.01%	140
2020 Q3	$294K	Sell	1,157 -43	-4%	-$10.7K	﹤0.01%	131
2020 Q2	$283K	Sell	1,200 -4,217	-78%	-$962K	﹤0.01%	131
2020 Q1	$1.1M	Buy	5,417 +3,900	+257%	+$852K	0.01%	120
2019 Q4	$366K	Hold	1,517	–	–	﹤0.01%	134
2019 Q3	$294K	Hold	1,517	–	–	﹤0.01%	136
2019 Q2	$280K	Hold	1,517	–	–	﹤0.01%	135
2019 Q1	$288K	Hold	1,517	–	–	﹤0.01%	134
2018 Q4	$295K	Hold	1,517	–	–	﹤0.01%	135
2018 Q3	$314K	Hold	1,517	–	–	﹤0.01%	128
2018 Q2	$280K	Sell	1,517 -18	-1%	-$3.18K	﹤0.01%	129
2018 Q1	$262K	Buy	1,535 +18	+1%	+$3.3K	﹤0.01%	129
2017 Q4	$264K	Hold	1,517	–	–	﹤0.01%	128
2017 Q3	$283K	Sell	1,517 -100	-6%	-$17.7K	﹤0.01%	125
2017 Q2	$278K	Hold	1,617	–	–	﹤0.01%	122
2017 Q1	$265K	Sell	1,617 -433	-21%	-$71.9K	﹤0.01%	128
2016 Q4	$300K	Hold	2,050	–	–	﹤0.01%	120
2016 Q3	$342K	Buy	2,050 +583	+40%	+$98.6K	﹤0.01%	117
2016 Q2	$223K	Buy	+1,467	New	+$228K	﹤0.01%	120

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

London Company of Virginia's AMGN Position: Q4 2023 in Review

London Company of Virginia sold out of Amgen (AMGN) in Q4 2023, closing a stake of 1,000 shares — an estimated $269K sold.

London Company of Virginia first reported a position in AMGN in Q2 2016 and held it in 30 quarters. The position peaked at $1.1M in Q1 2020. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

London Company of Virginia reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
London Company of Virginia sold 1,000 Amgen shares in Q4 2023, an estimated $269K.
London Company of Virginia first reported a position in Amgen in Q2 2016 and held it in 30 quarters.
London Company of Virginia's Amgen position peaked at $1.1M in Q1 2020.
2,715 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on London Company of Virginia's 13F filing for Q4 2023, filed 14 Feb 2024.